About Exorenal

Exorenal develops artificial kidney and dialysis machines that utilize advanced filtration technologies to efficiently remove toxins and excess fluids from patients with kidney failure. Their devices provide reliable renal replacement therapy, improving patient outcomes in chronic kidney disease management.

```xml <problem> Patients with kidney failure often face limitations due to the size and complexity of traditional hemodialysis machines, restricting their access to treatment and impacting their quality of life. Existing portable dialysis solutions may not offer the same performance as stationary devices found in hospitals and clinics. </problem> <solution> Exorenal is developing a compact hemodialysis system designed to provide effective renal replacement therapy in a portable format. The xKidney, their lead product, is a small and lightweight HD device that aims to match the performance of industry-standard stationary machines through advanced APB Technology. Paired with the XRO, a portable reverse osmosis machine, the system delivers dialysate-quality water from tap-to-treatment, increasing accessibility to hemodialysis in various settings. Exorenal's goal is to empower patients with greater freedom and convenience in managing their kidney disease. </solution> <features> - xKidney: A compact hemodialysis device utilizing APB Technology for efficient toxin and fluid removal. - XRO: A portable reverse osmosis machine providing dialysate-quality water from tap-to-treatment. - Intended to match the balancing accuracy and performance of industry-leading stationary hemodialysis machines. - Designed for ease of setup, operation, and maintenance for both patients and providers. </features> <target_audience> The primary target audience includes patients with kidney failure requiring hemodialysis, as well as healthcare providers and clinics seeking more accessible and portable dialysis solutions. </target_audience> ```

What does Exorenal do?

Where is Exorenal located?

Exorenal is based in Baltimore, United States.

When was Exorenal founded?

Exorenal was founded in 2020.

How much funding has Exorenal raised?

Exorenal has raised 5300000.

Location

Baltimore, United States

Founded

2020

Funding

5300000

Employees

2 employees

Find Investable Startups and Competitors

Search thousands of startups using natural language

AI voice (2021+)underground pipe robots energy flexibility software

Start Searching

Exorenal

⚠️ AI-generated overview based on web search data – may contain errors, please verify information yourself! You can claim this account with your email domain to make edits.

Executive Summary

exorenal.com 50+

Founded 2020 – Baltimore, United States

Funding

Estimated Funding

$5M+

Team (<5)

No team information available.

Company Description

Problem

Patients with kidney failure often face limitations due to the size and complexity of traditional hemodialysis machines, restricting their access to treatment and impacting their quality of life. Existing portable dialysis solutions may not offer the same performance as stationary devices found in hospitals and clinics.

Solution

Exorenal is developing a compact hemodialysis system designed to provide effective renal replacement therapy in a portable format. The xKidney, their lead product, is a small and lightweight HD device that aims to match the performance of industry-standard stationary machines through advanced APB Technology. Paired with the XRO, a portable reverse osmosis machine, the system delivers dialysate-quality water from tap-to-treatment, increasing accessibility to hemodialysis in various settings. Exorenal's goal is to empower patients with greater freedom and convenience in managing their kidney disease.

Features

xKidney: A compact hemodialysis device utilizing APB Technology for efficient toxin and fluid removal.

XRO: A portable reverse osmosis machine providing dialysate-quality water from tap-to-treatment.

Intended to match the balancing accuracy and performance of industry-leading stationary hemodialysis machines.

Designed for ease of setup, operation, and maintenance for both patients and providers.

Target Audience

The primary target audience includes patients with kidney failure requiring hemodialysis, as well as healthcare providers and clinics seeking more accessible and portable dialysis solutions.